z-logo
open-access-imgOpen Access
DETERMINATION OF TELMISARTAN IN PHARMACEUTICAL FORMULATIONS BY REVERSE PHASE-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Author(s) -
Manoj S. Charde,
Abhinav Gupta,
R. D. Chakole
Publication year - 2012
Publication title -
international journal of phytopharmacy
Language(s) - English
Resource type - Journals
ISSN - 2277-2928
DOI - 10.7439/ijpp.v2i2.440
Subject(s) - telmisartan , chromatography , high performance liquid chromatography , chemistry , phase (matter) , medicine , organic chemistry , blood pressure

A simple, sensitive and reproducible reverse-phase high performance liquid chromatographic (RP-HPLC) method has been developed for the quantitative estimation of Telmisartan (TELM) in the pharmaceutical formulations. Chromatographic separation was achieved on a 250 × 4.6 mm, 5μ, Waters symmetry column. The flow rate was 1 ml/min and eluent was monitored by absorbance at 230 nm using a mixture of Methanol and Acetonitrile (pH 3.0±0.01) in the ratio of 30:70 (v/v). The retention time of Telmisartan was found to be 7.9 min. Calibration plots were linear in the concentration range of 10-50 μg/ml for Telmisartan with correlation coefficient (R2) 0.999. The proposed method was validated by testing its linearity, recovery, specificity, system suitability, precision (Interday, intraday, analyst and instrument precision), robustness and LOD/LOQ values and it was successfully employed for the determination of Telmisartan in pharmaceutical tablet formulations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here